Download PDF

Other users also viewed these articles

Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP) Laura Francisco; Marta Cruz-Cañete; Carlos Pérez; José Antonio Couceiro; Enrique Otheo; Cristian Launes; Carlos Rodrigo; Ana Belén Jiménez; Marta Llorente; Abián Montesdeoca; José Rumbao; Cristina Calvo; Susana Frago; Alfredo Tagarro;
An Pediatr (Barc). 2023;99:257-63
Respiratory syncytial virus infections requiring hospitalization in patients with primary immunodeficiency Luis Ignacio González-Granado; Andrea Martín-Nalda; Laia Alsina; Olaf Neth; Manuel Santamaría; Pere Soler-Palacín;
An Pediatr (Barc). 2022;96:492-500
Increasing trend in patients with life-limiting and complex chronic conditions Javier Ochoa-Brezmes; Pablo del Villar Guerra; Jesús Andrés de Llano; Jesús Manuel Marugán de Miguelsanz;
An Pediatr (Barc). 2024;101:95-103